Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)

[Display omitted] Computer aided drug design led to a new class of spiro-barbiturates (e.g., 4a, MMP-13 K i = 4.7 nM) that are potent inhibitors of MMP-13.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bioorganic & medicinal chemistry letters 2005-02, Vol.15 (4), p.1101-1106
Hauptverfasser:	Kim, Soong-Hoon, Pudzianowski, Andrew T., Leavitt, Kenneth J., Barbosa, Joseph, McDonnell, Patricia A., Metzler, William J., Rankin, Bruce M., Liu, Richard, Vaccaro, Wayne, Pitts, William
Format:	Artikel
Sprache:	eng
Schlagworte:	Barbiturates - chemical synthesis Barbiturates - pharmacology Barbituric acid Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Computer Simulation Computer-Aided Design Drug Design Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Humans Kinetics Matrix Metalloproteinase 13 Matrix Metalloproteinase Inhibitors Medical sciences MMP-13 inhibition Models, Molecular Osteoarthritis - drug therapy Pharmacology. Drug treatments Spiro Compounds - chemical synthesis Spiro Compounds - pharmacology Structure-Activity Relationship Structure-based design
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[Display omitted] Computer aided drug design led to a new class of spiro-barbiturates (e.g., 4a, MMP-13 K i = 4.7 nM) that are potent inhibitors of MMP-13.
ISSN:	0960-894X 1464-3405
DOI:	10.1016/j.bmcl.2004.12.016